Clinical Molecular Genetics: industry payments
Drug and device makers reported $4,027,397 in payments to providers registered in this specialty across Open Payments program years 2019–2025.
- Providers
- 34
- Received a payment
- 34 (100.0%)
- Total reported
- $4M
- Average, those paid
- $118,453
The average is computed only over providers who received something, because including the 0 who received nothing would produce a number that describes neither group. Totals are dominated by a small number of large royalty and consulting arrangements; the typical payment in this specialty is far smaller than the average implies.
By state
| State | Providers | Total reported | Per provider |
|---|---|---|---|
| Indiana | 4 | $2,454,660 | $613,665 |
| Texas | 5 | $1,310,739 | $262,148 |
| Connecticut | 1 | $245,699 | $245,699 |
| Washington | 3 | $7,284 | $2,428 |
| Puerto Rico | 1 | $4,389 | $4,389 |
| Georgia | 1 | $2,257 | $2,257 |
| Florida | 3 | $760 | $253 |
| California | 3 | $434 | $145 |
| Tennessee | 2 | $338 | $169 |
| New York | 3 | $288 | $96 |
| Iowa | 1 | $190 | $190 |
| North Carolina | 1 | $105 | $105 |
| Minnesota | 1 | $100 | $100 |
| New Jersey | 1 | $47 | $47 |
| Alabama | 1 | $43 | $43 |
| Utah | 1 | $31 | $31 |
| Massachusetts | 1 | $20 | $20 |
| Pennsylvania | 1 | $13 | $13 |